Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?

Marlies de Ligt1, Silvie Timmers1, Patrick Schrauwen1

  • 1Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, 6200MD Maastricht, The Netherlands.

Insights

Resveratrol, a natural polyphenol, shows promise in combating obesity by mimicking calorie restriction through sirtuin 1 (SIRT1) activation. While animal studies are encouraging, human clinical trial data on resveratrol

Area of Science:

  • Metabolic health and nutrition
  • Molecular biology and aging

Background:

  • Obesity and metabolic disorders require new preventive and therapeutic strategies.
  • Resveratrol, a natural polyphenol, is investigated for its health benefits.
  • Sirtuin 1 (SIRT1) plays a key role in energy homeostasis and mitochondrial function.

Purpose of the Study:

  • To review pre-clinical and clinical studies on resveratrol's effects on obesity.
  • To assess the translation of resveratrol's benefits from animal models to human outcomes.
  • To provide an overview of resveratrol's impact on obesity-related health issues.

Main Methods:

  • Literature review of animal studies on resveratrol and obesity.
  • Analysis of placebo-controlled clinical trials in humans.
  • Examination of resveratrol's mechanism of action involving SIRT1.

Main Results:

  • Animal studies suggest resveratrol improves mitochondrial function, glucose metabolism, body composition, and reduces liver fat.
  • Resveratrol's effects in animal models are linked to SIRT1 activation, mimicking calorie restriction.
  • Limited human clinical trial data currently confirms these benefits.

Conclusions:

  • Resveratrol demonstrates potential therapeutic benefits for obesity in pre-clinical studies.
  • Further robust human clinical trials are needed to validate resveratrol's efficacy for obesity.
  • Translating resveratrol's promising pre-clinical findings into patient benefits remains a key challenge.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
310
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
425
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
12.6K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.3K